Helena Bertilsson

1.6k total citations
47 papers, 1.2k citations indexed

About

Helena Bertilsson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Helena Bertilsson has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 17 papers in Molecular Biology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Helena Bertilsson's work include Prostate Cancer Diagnosis and Treatment (26 papers), Prostate Cancer Treatment and Research (22 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). Helena Bertilsson is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (26 papers), Prostate Cancer Treatment and Research (22 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). Helena Bertilsson collaborates with scholars based in Norway, Netherlands and United Kingdom. Helena Bertilsson's co-authors include May‐Britt Tessem, Tone F. Bathen, Anders Angelsen, Kirsten M. Selnæs, Guro F. Giskeødegård, Trond Viset, Morten Beck Rye, Jostein Halgunset, Alan J. Wright and Ingrid S. Gribbestad and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Helena Bertilsson

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helena Bertilsson Norway 21 606 446 347 221 181 47 1.2k
Qing Zhong China 19 503 0.8× 149 0.3× 222 0.6× 68 0.3× 69 0.4× 77 970
Aarti Asnani United States 21 488 0.8× 213 0.5× 107 0.3× 107 0.5× 53 0.3× 59 1.4k
Yanqi He China 20 370 0.6× 149 0.3× 182 0.5× 80 0.4× 107 0.6× 47 875
Ken Y. Yoneda United States 21 657 1.1× 646 1.4× 261 0.8× 61 0.3× 34 0.2× 63 1.6k
Kathy Gately Ireland 24 808 1.3× 515 1.2× 366 1.1× 232 1.0× 15 0.1× 79 1.8k
Carol D Cheli United States 17 301 0.5× 518 1.2× 102 0.3× 126 0.6× 41 0.2× 40 1.0k
María Sereno Spain 19 405 0.7× 222 0.5× 220 0.6× 35 0.2× 23 0.1× 62 1.1k
Karen J. Klamerus United States 17 500 0.8× 382 0.9× 142 0.4× 122 0.6× 28 0.2× 41 1.3k
Bin Lu China 16 618 1.0× 412 0.9× 295 0.9× 109 0.5× 13 0.1× 59 1.7k
Shujun Xia China 19 350 0.6× 49 0.1× 157 0.5× 101 0.5× 37 0.2× 56 871

Countries citing papers authored by Helena Bertilsson

Since Specialization
Citations

This map shows the geographic impact of Helena Bertilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Bertilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Bertilsson more than expected).

Fields of papers citing papers by Helena Bertilsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Bertilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Bertilsson. The network helps show where Helena Bertilsson may publish in the future.

Co-authorship network of co-authors of Helena Bertilsson

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Bertilsson. A scholar is included among the top collaborators of Helena Bertilsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Bertilsson. Helena Bertilsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elschot, Mattijs, et al.. (2024). Repeat Prostate-specific Antigen Testing Improves Risk-based Selection of Men for Prostate Biopsy After Magnetic Resonance Imaging. European Urology Open Science. 65. 21–28. 2 indexed citations
2.
Andersen, Maria, Sebastian Krossa, Maximilian Wess, et al.. (2024). Spatial transcriptomics reveals strong association between SFRP4 and extracellular matrix remodeling in prostate cancer. Communications Biology. 7(1). 1462–1462. 4 indexed citations
3.
Sandsmark, Elise, et al.. (2023). The impact of pre-processing and disease characteristics on reproducibility of T2-weighted MRI radiomics features. Magnetic Resonance Materials in Physics Biology and Medicine. 36(6). 945–956. 6 indexed citations
4.
Remmers, Sebastiaan, et al.. (2023). Performance of magnetic resonance imaging‐based prostate cancer risk calculators and decision strategies in two large European medical centres. British Journal of Urology. 133(3). 278–288. 4 indexed citations
5.
Elschot, Mattijs, et al.. (2021). Exploring the diagnostic potential of adding T2 dependence in diffusion-weighted MR imaging of the prostate. PLoS ONE. 16(5). e0252387–e0252387. 3 indexed citations
6.
Bertilsson, Helena, et al.. (2021). Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies. Frontiers in Oncology. 11. 745657–745657. 10 indexed citations
7.
Selnæs, Kirsten M., Mattijs Elschot, May‐Britt Tessem, et al.. (2020). Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI. Frontiers in Oncology. 10. 582092–582092. 11 indexed citations
8.
9.
Giskeødegård, Guro F., Trygve Andreassen, Helena Bertilsson, May‐Britt Tessem, & Tone F. Bathen. (2019). The effect of sampling procedures and day-to-day variations in metabolomics studies of biofluids. Analytica Chimica Acta. 1081. 93–102. 16 indexed citations
10.
Elschot, Mattijs, et al.. (2018). The Effect of Including Bone in Dixon-Based Attenuation Correction for 18F-Fluciclovine PET/MRI of Prostate Cancer. Journal of Nuclear Medicine. 59(12). 1913–1917. 13 indexed citations
11.
Andersen, Maria, Guro F. Giskeødegård, Elin Richardsen, et al.. (2018). Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma. Scientific Reports. 8(1). 14269–14269. 56 indexed citations
12.
Esmaeili, Morteza, Tom W. J. Scheenen, Mattijs Elschot, et al.. (2018). Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer. Frontiers in Oncology. 8. 516–516. 4 indexed citations
13.
Rye, Morten Beck, Helena Bertilsson, Maria Andersen, et al.. (2018). Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized. BMC Cancer. 18(1). 478–478. 15 indexed citations
14.
Andersen, Sigve, Elin Richardsen, Mehrdad Rakaee, et al.. (2017). Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer. PLoS ONE. 12(11). e0189000–e0189000. 2 indexed citations
15.
Giskeødegård, Guro F., Elise Sandsmark, Helena Bertilsson, et al.. (2017). Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy. British Journal of Cancer. 117(11). 1656–1664. 36 indexed citations
16.
Tessem, May‐Britt, Helena Bertilsson, Anders Angelsen, et al.. (2016). A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer. PLoS ONE. 11(4). e0153727–e0153727. 25 indexed citations
17.
Giskeødegård, Guro F., Ailin Falkmo Hansen, Helena Bertilsson, et al.. (2015). Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia. British Journal of Cancer. 113(12). 1712–1719. 80 indexed citations
18.
Tessem, May‐Britt, Tone F. Bathen, Helena Bertilsson, et al.. (2014). Identification of metabolites from 2D 1H-13C HSQC NMR using peak correlation plots. BMC Bioinformatics. 15(1). 413–413. 24 indexed citations
19.
Giskeødegård, Guro F., Helena Bertilsson, Kirsten M. Selnæs, et al.. (2013). Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness. PLoS ONE. 8(4). e62375–e62375. 154 indexed citations
20.
Bertilsson, Helena, et al.. (2010). RNA quality in fresh frozen prostate tissue from patients operated with radical prostatectomy. Scandinavian Journal of Clinical and Laboratory Investigation. 70(1). 45–53. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Zhong Breakdown of academic impact, for papers by Aarti Asnani Breakdown of academic impact, for papers by Yanqi He Breakdown of academic impact, for papers by Ken Y. Yoneda Breakdown of academic impact, for papers by Kathy Gately Breakdown of academic impact, for papers by Carol D Cheli Breakdown of academic impact, for papers by María Sereno Breakdown of academic impact, for papers by Karen J. Klamerus Breakdown of academic impact, for papers by Bin Lu Breakdown of academic impact, for papers by Shujun Xia
Rankless by CCL
2026